|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | G01N 33/48 | (2006.01) |
| G01N 33/50 | (2006.01) | ||
| C12Q 1/56 | (2006.01) |
| (11) | Number of the document | 2946206 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14740167.3 |
| Date of filing the European patent application | 2014-01-17 | |
| (97) | Date of publication of the European application | 2015-11-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-09 |
| (46) | Date of publication of the claims translation | 2019-04-25 |
| (86) | Number | PCT/US2014/012090 |
| Date | 2014-01-17 |
| (87) | Number | WO 2014/113701 |
| Date | 2014-07-24 |
| (30) | Number | Date | Country code |
| 201361754600 P | 2013-01-20 | US |
| (72) |
JOSEPH, Kusumam, US
KAPLAN, Allen, P., US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka,
JP
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | PKAL sąlygotų sutrikimų vertinimas, tyrimas ir gydymas |
| EVALUATION, ASSAYS AND TREATMENT OF PKAL-MEDIATED DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 12 | 289.00 EUR |
| 2026-01-17 |